Remedy Logic
PrivateLast Round
Seed
May 31, 2021
Est. Valuation
$45.5M
Total Funding Raised
$4.55M
Company Overview
Remedy Logic is a healthtech company that provides an AI-powered platform for spine MRI interpretation to streamline radiology workflows and improve diagnostic accuracy.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Healthcare Analytics, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Remedy Logic Comparables
Compare Remedy Logic with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CoLumbo | 90% | |
| MSKai | 88% | |
| ImageBiopsy Lab | 78% | |
Remedy Logic Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 31, 2021 |
Remedy Logic Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Epsilon Health Investors | Seed |
| Max Ventures | Seed |
| Antler | Seed |
| WorldQuant Ventures | Seed |
| ACE & Company | Seed |
| Brand New Matter | Seed |
| Correlation Ventures | Seed |
Remedy Logic Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Remedy Logic's valuation, stock price, and market status.